131 related articles for article (PubMed ID: 29805791)
1. Bone loss during neoadjuvant/adjuvant chemotherapy for early stage breast cancer: A retrospective cohort study.
Axelsen CT; Jensen AB; Jakobsen EH; Bechmann T
Mol Clin Oncol; 2018 Jun; 8(6):767-772. PubMed ID: 29805791
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.
Gnant M; Mlineritsch B; Luschin-Ebengreuth G; Kainberger F; Kässmann H; Piswanger-Sölkner JC; Seifert M; Ploner F; Menzel C; Dubsky P; Fitzal F; Bjelic-Radisic V; Steger G; Greil R; Marth C; Kubista E; Samonigg H; Wohlmuth P; Mittlböck M; Jakesz R;
Lancet Oncol; 2008 Sep; 9(9):840-9. PubMed ID: 18718815
[TBL] [Abstract][Full Text] [Related]
3. Change in bone mineral density during adjuvant chemotherapy for early-stage breast cancer.
Christensen CØ; Cronin-Fenton D; Frøslev T; Hermann AP; Ewertz M
Support Care Cancer; 2016 Oct; 24(10):4229-36. PubMed ID: 27146497
[TBL] [Abstract][Full Text] [Related]
4. Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer.
Hong AR; Kim JH; Lee KH; Kim TY; Im SA; Kim TY; Moon HG; Han WS; Noh DY; Kim SW; Shin CS
Osteoporos Int; 2017 Apr; 28(4):1413-1422. PubMed ID: 28083668
[TBL] [Abstract][Full Text] [Related]
5. Antineoplastic treatment effect on bone mineral density in Mexican breast cancer patients.
Monroy-Cisneros K; Esparza-Romero J; Valencia ME; Guevara-Torres AG; Méndez-Estrada RO; Anduro-Corona I; Astiazarán-García H
BMC Cancer; 2016 Nov; 16(1):860. PubMed ID: 27821086
[TBL] [Abstract][Full Text] [Related]
6. Changes on bone mineral density after adjuvant treatment in women with non-metastatic breast cancer.
Rodríguez-Rodríguez LM; Rodríguez-Rodríguez EM; Oramas-Rodríguez JM; Santolaria-Fernandez F; Llanos M; Cruz J; Martínez A; González-Reimers E; Gómez A; Batista N
Breast Cancer Res Treat; 2005 Sep; 93(1):75-83. PubMed ID: 16184462
[TBL] [Abstract][Full Text] [Related]
7. Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.
Powles TJ; Hickish T; Kanis JA; Tidy A; Ashley S
J Clin Oncol; 1996 Jan; 14(1):78-84. PubMed ID: 8558225
[TBL] [Abstract][Full Text] [Related]
8. Management of cancer-treatment-induced bone loss in postmenopausal women undergoing adjuvant breast cancer therapy: a Z-FAST update.
Brufsky A
Semin Oncol; 2006 Apr; 33(2 Suppl 7):S13-7. PubMed ID: 16730272
[TBL] [Abstract][Full Text] [Related]
9. Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients.
Saarto T; Blomqvist C; Välimäki M; Mäkelä P; Sarna S; Elomaa I
J Clin Oncol; 1997 Apr; 15(4):1341-7. PubMed ID: 9193325
[TBL] [Abstract][Full Text] [Related]
10. Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment.
Vehmanen L; Saarto T; Elomaa I; Mäkelä P; Välimäki M; Blomqvist C
Eur J Cancer; 2001 Dec; 37(18):2373-8. PubMed ID: 11720830
[TBL] [Abstract][Full Text] [Related]
11. Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results.
Bundred NJ; Campbell ID; Davidson N; DeBoer RH; Eidtmann H; Monnier A; Neven P; von Minckwitz G; Miller JC; Schenk NL; Coleman RE
Cancer; 2008 Mar; 112(5):1001-10. PubMed ID: 18205185
[TBL] [Abstract][Full Text] [Related]
12. Changes in Bone Mineral Density After Prophylactic Bilateral Salpingo-Oophorectomy in Carriers of a BRCA Mutation.
Kotsopoulos J; Hall E; Finch A; Hu H; Murphy J; Rosen B; Narod SA; Cheung AM
JAMA Netw Open; 2019 Aug; 2(8):e198420. PubMed ID: 31390031
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.
Vehmanen L; Elomaa I; Blomqvist C; Saarto T
J Clin Oncol; 2006 Feb; 24(4):675-80. PubMed ID: 16446340
[TBL] [Abstract][Full Text] [Related]
14. A Randomized Controlled Trial of Exercise to Prevent Bone Loss in Premenopausal Women with Breast Cancer.
Tabatabai LS; Bloom J; Stewart S; Sellmeyer DE
J Womens Health (Larchmt); 2019 Jan; 28(1):87-92. PubMed ID: 30312118
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates may protect against bone loss in postmenopausal women with early breast cancer receiving adjuvant aromatase inhibitor therapy: results from a meta-analysis.
Su G; Xiang Y; He G; Jiang C; Li C; Yan Z; Zhong Y
Arch Med Res; 2014 Oct; 45(7):570-9. PubMed ID: 25450582
[TBL] [Abstract][Full Text] [Related]
16. The effect of ovarian dysfunction on bone mineral density in breast cancer patients 10 years after adjuvant chemotherapy.
Vehmanen LK; Elomaa I; Blomqvist CP; Saarto T
Acta Oncol; 2014 Jan; 53(1):75-9. PubMed ID: 23713891
[TBL] [Abstract][Full Text] [Related]
17. Bone Health in Premenopausal Chinese Patients after Adjuvant Chemotherapy for Early Breast Cancer.
Yip CHW; Liem GS; Mo FKF; Pang E; Lei YY; Li L; Yip CCH; Koh J; Ng RYW; Suen JJS; Yeo W
Breast Care (Basel); 2020 Dec; 15(6):655-666. PubMed ID: 33447241
[TBL] [Abstract][Full Text] [Related]
18. Osteoporosis after adjuvant treatment for early-stage breast cancer.
Christensen CØ; Jensen MB; Hermann AP; Ewertz M
Dan Med J; 2020 Oct; 67(11):. PubMed ID: 33215600
[TBL] [Abstract][Full Text] [Related]
19. Bone health in urban midlife Malaysian women: risk factors and prevention.
Lim PS; Ong FB; Adeeb N; Seri SS; Noor-Aini MY; Shamsuddin K; Hapizah N; Mohamed AL; Mokhtar A; Wan HW
Osteoporos Int; 2005 Dec; 16(12):2069-79. PubMed ID: 16234999
[TBL] [Abstract][Full Text] [Related]
20. Effect of denosumab on low bone mineral density in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: 24-month results.
Nakatsukasa K; Koyama H; Ouchi Y; Ono H; Sakaguchi K; Matsuda T; Kato M; Ishikawa T; Yamada K; Yoshimura M; Koizumi K; Sakurai T; Shigematsu H; Takahashi S; Taira S; Suzuki M; Narui K; Niikura N; Hasegawa Y; Miura D; Konishi E; Taguchi T;
Breast Cancer; 2019 Jan; 26(1):106-112. PubMed ID: 30054855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
